Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2000 Nov;69(5):623–629. doi: 10.1136/jnnp.69.5.623

Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease

H Yamauchi 1, H Fukuyama 1, Y Nagahama 1, Y Katsumi 1, T Hayashi 1, C Oyanagi 1, J Konishi 1, H Shio 1
PMCID: PMC1763404  PMID: 11032614

Abstract

OBJECTIVES—The loss of the neurons in layer 3, one of the groups of cortical neurons most vulnerable in various degenerative brain diseases, results in axonal degeneration leading to atrophy of the corpus callosum. Previous studies showed callosal atrophy in three degenerative dementias: frontotemporal dementia (FTD), progressive supranuclear palsy (PSP), and Alzheimer's disease (AD). However, it is unclear whether a characteristic pattern of atrophy is present in each. The objective of this study was to investigate whether the pattern of the callosal atrophy was different among patients with FTD, PSP, or early onset AD.
METHODS—Eleven patients with FTD, nine patients with PSP, 16 patients with early onset AD, and 23 normal controls, all age and sex matched, were studied using MRI. The ratios of midsagittal corpus callosum areas to the midline internal skull surface area on T1 weighted images were analyzed. The corpus callosum was divided into quarters: the anterior, middle-anterior, middle-posterior, and posterior portions.
RESULTS—Compared with controls, all three patient groups had significantly decreased total callosal/skull area ratio. An analysis of covariance adjusted for the total callosal area/skull area ratio showed that the anterior quarter callosal/skull area ratio in FTD, the middle-anterior quarter area ratio in PSP, and the posterior quarter area ratio in AD were significantly smaller than those in the other three groups.
CONCLUSION—Although atrophy of the corpus callosum is not specific to any degenerative dementia, the patterns of the atrophy are different among patients with FTD, PSP, or early onset AD. Differential patterns of callosal atrophy might reflect characteristic patterns of neocortical involvement in each degenerative dementia.



Full Text

The Full Text of this article is available as a PDF (182.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbas H., Pandya D. N. Topography of commissural fibers of the prefrontal cortex in the rhesus monkey. Exp Brain Res. 1984;55(1):187–191. doi: 10.1007/BF00240516. [DOI] [PubMed] [Google Scholar]
  2. Biegon A., Eberling J. L., Richardson B. C., Roos M. S., Wong S. T., Reed B. R., Jagust W. J. Human corpus callosum in aging and Alzheimer's disease: a magnetic resonance imaging study. Neurobiol Aging. 1994 Jul-Aug;15(4):393–397. doi: 10.1016/0197-4580(94)90070-1. [DOI] [PubMed] [Google Scholar]
  3. Daniel S. E., de Bruin V. M., Lees A. J. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain. 1995 Jun;118(Pt 3):759–770. doi: 10.1093/brain/118.3.759. [DOI] [PubMed] [Google Scholar]
  4. Duara R., Barker W., Luis C. A. Frontotemporal dementia and Alzheimer's disease: differential diagnosis. Dement Geriatr Cogn Disord. 1999;10 (Suppl 1):37–42. doi: 10.1159/000051210. [DOI] [PubMed] [Google Scholar]
  5. Edwards-Lee T., Miller B. L., Benson D. F., Cummings J. L., Russell G. L., Boone K., Mena I. The temporal variant of frontotemporal dementia. Brain. 1997 Jun;120(Pt 6):1027–1040. doi: 10.1093/brain/120.6.1027. [DOI] [PubMed] [Google Scholar]
  6. Ernst T., Chang L., Melchor R., Mehringer C. M. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology. 1997 Jun;203(3):829–836. doi: 10.1148/radiology.203.3.9169712. [DOI] [PubMed] [Google Scholar]
  7. Folstein M. F., Folstein S. E., McHugh P. R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  8. Frisoni G. B., Beltramello A., Geroldi C., Weiss C., Bianchetti A., Trabucchi M. Brain atrophy in frontotemporal dementia. J Neurol Neurosurg Psychiatry. 1996 Aug;61(2):157–165. doi: 10.1136/jnnp.61.2.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Garraux G., Salmon E., Degueldre C., Lemaire C., Laureys S., Franck G. Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia. Neuroimage. 1999 Aug;10(2):149–162. doi: 10.1006/nimg.1999.0463. [DOI] [PubMed] [Google Scholar]
  10. Hampel H., Teipel S. J., Alexander G. E., Horwitz B., Teichberg D., Schapiro M. B., Rapoport S. I. Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis. Arch Neurol. 1998 Feb;55(2):193–198. doi: 10.1001/archneur.55.2.193. [DOI] [PubMed] [Google Scholar]
  11. Hof P. R., Delacourte A., Bouras C. Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases. Acta Neuropathol. 1992;84(1):45–51. doi: 10.1007/BF00427214. [DOI] [PubMed] [Google Scholar]
  12. Holzer M., Holzapfel H. P., Zedlick D., Brückner M. K., Arendt T. Abnormally phosphorylated tau protein in Alzheimer's disease: heterogeneity of individual regional distribution and relationship to clinical severity. Neuroscience. 1994 Nov;63(2):499–516. doi: 10.1016/0306-4522(94)90546-0. [DOI] [PubMed] [Google Scholar]
  13. Janowsky J. S., Kaye J. A., Carper R. A. Atrophy of the corpus callosum in Alzheimer's disease versus healthy aging. J Am Geriatr Soc. 1996 Jul;44(7):798–803. doi: 10.1111/j.1532-5415.1996.tb03736.x. [DOI] [PubMed] [Google Scholar]
  14. Kaufer D. I., Miller B. L., Itti L., Fairbanks L. A., Li J., Fishman J., Kushi J., Cummings J. L. Midline cerebral morphometry distinguishes frontotemporal dementia and Alzheimer's disease. Neurology. 1997 Apr;48(4):978–985. doi: 10.1212/wnl.48.4.978. [DOI] [PubMed] [Google Scholar]
  15. Kitagaki H., Mori E., Yamaji S., Ishii K., Hirono N., Kobashi S., Hata Y. Frontotemporal dementia and Alzheimer disease: evaluation of cortical atrophy with automated hemispheric surface display generated with MR images. Radiology. 1998 Aug;208(2):431–439. doi: 10.1148/radiology.208.2.9680572. [DOI] [PubMed] [Google Scholar]
  16. Laissy J. P., Patrux B., Duchateau C., Hannequin D., Hugonet P., Ait-Yahia H., Thiebot J. Midsagittal MR measurements of the corpus callosum in healthy subjects and diseased patients: a prospective survey. AJNR Am J Neuroradiol. 1993 Jan-Feb;14(1):145–154. [PMC free article] [PubMed] [Google Scholar]
  17. Litvan I., Agid Y., Jankovic J., Goetz C., Brandel J. P., Lai E. C., Wenning G., D'Olhaberriague L., Verny M., Chaudhuri K. R. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology. 1996 Apr;46(4):922–930. doi: 10.1212/wnl.46.4.922. [DOI] [PubMed] [Google Scholar]
  18. Litvan I. Progressive supranuclear palsy revisited. Acta Neurol Scand. 1998 Aug;98(2):73–84. [PubMed] [Google Scholar]
  19. Lopez O. L., Litvan I., Catt K. E., Stowe R., Klunk W., Kaufer D. I., Becker J. T., DeKosky S. T. Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology. 1999 Oct 12;53(6):1292–1299. doi: 10.1212/wnl.53.6.1292. [DOI] [PubMed] [Google Scholar]
  20. Lyoo I. K., Satlin A., Lee C. K., Renshaw P. F. Regional atrophy of the corpus callosum in subjects with Alzheimer's disease and multi-infarct dementia. Psychiatry Res. 1997 May 16;74(2):63–72. doi: 10.1016/s0925-4927(97)00009-7. [DOI] [PubMed] [Google Scholar]
  21. Mann D. M., South P. W. The topographic distribution of brain atrophy in frontal lobe dementia. Acta Neuropathol. 1993;85(3):334–340. doi: 10.1007/BF00227731. [DOI] [PubMed] [Google Scholar]
  22. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar]
  23. Mesulam M. M. Large-scale neurocognitive networks and distributed processing for attention, language, and memory. Ann Neurol. 1990 Nov;28(5):597–613. doi: 10.1002/ana.410280502. [DOI] [PubMed] [Google Scholar]
  24. Neary D., Snowden J. S., Gustafson L., Passant U., Stuss D., Black S., Freedman M., Kertesz A., Robert P. H., Albert M. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998 Dec;51(6):1546–1554. doi: 10.1212/wnl.51.6.1546. [DOI] [PubMed] [Google Scholar]
  25. Pandya D. N., Karol E. A., Heilbronn D. The topographical distribution of interhemispheric projections in the corpus callosum of the rhesus monkey. Brain Res. 1971 Sep 10;32(1):31–43. doi: 10.1016/0006-8993(71)90153-3. [DOI] [PubMed] [Google Scholar]
  26. Vermersch P., Robitaille Y., Bernier L., Wattez A., Gauvreau D., Delacourte A. Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement. Acta Neuropathol. 1994;87(6):572–577. doi: 10.1007/BF00293317. [DOI] [PubMed] [Google Scholar]
  27. Waldemar G., Bruhn P., Kristensen M., Johnsen A., Paulson O. B., Lassen N. A. Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study. J Neurol Neurosurg Psychiatry. 1994 Mar;57(3):285–295. doi: 10.1136/jnnp.57.3.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wible C. G., Shenton M. E., Hokama H., Kikinis R., Jolesz F. A., Metcalf D., McCarley R. W. Prefrontal cortex and schizophrenia. A quantitative magnetic resonance imaging study. Arch Gen Psychiatry. 1995 Apr;52(4):279–288. doi: 10.1001/archpsyc.1995.03950160029007. [DOI] [PubMed] [Google Scholar]
  29. Yamauchi H., Fukuyama H., Harada K., Nabatame H., Ogawa M., Ouchi Y., Kimura J., Konishi J. Callosal atrophy parallels decreased cortical oxygen metabolism and neuropsychological impairment in Alzheimer's disease. Arch Neurol. 1993 Oct;50(10):1070–1074. doi: 10.1001/archneur.1993.00540100061017. [DOI] [PubMed] [Google Scholar]
  30. Yamauchi H., Fukuyama H., Nagahama Y., Katsumi Y., Dong Y., Konishi J., Kimura J. Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy. Ann Neurol. 1997 May;41(5):606–614. doi: 10.1002/ana.410410509. [DOI] [PubMed] [Google Scholar]
  31. Yamauchi H., Fukuyama H., Ouchi Y., Nagahama Y., Kimura J., Asato R., Konishi J. Corpus callosum atrophy in amyotrophic lateral sclerosis. J Neurol Sci. 1995 Dec;134(1-2):189–196. doi: 10.1016/0022-510x(95)00220-6. [DOI] [PubMed] [Google Scholar]
  32. de Lacoste M. C., Kirkpatrick J. B., Ross E. D. Topography of the human corpus callosum. J Neuropathol Exp Neurol. 1985 Nov;44(6):578–591. doi: 10.1097/00005072-198511000-00004. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES